Skip to content

Common Stock at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$292M0.0%
Eli Lilly logo
Eli LillyLLY
$590M-0.4%
Amgen logo
AmgenAMGN
2.8B0.0%
Biogen logo
BiogenBIIB
$100K0.0%
AbbVie logo
AbbVieABBV
$18M0.0%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$54K+68.8%

Other financials

Income statement

See full
Revenue$25.6M-8.0%
Operating income-$34.6M-25.8%
Net income-$52.9M-34.5%
EPS (diluted)-$1.84-43.8%

Balance sheet

See full
Cash & equivalents$248.5M+152%
Total debt$13.6K-99.9%
Total equity$12.7M-62.5%
Total assets$329.7M-21.9%

Cash flow

See full
Operating cash flow-$25.9M-142%
CapEx$17.0K-51.4%
Free cash flow-$25.9M-142%

Valuation

See full
Market cap$1.73B+180%
Enterprise value$1.48B+176%
P/S7.4×+1.9×

Profitability

See full
Operating margin17.6%+9.6pp
Net margin-49.9%-22.6pp
FCF margin1.9%+1.0pp

Returns & leverage

See full
Return on equity-343.8%-1,012pp
Debt / equity-0.5×
Current ratio7.6×-0.7×

Where this comes from

Reported directly by AnaptysBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about AnaptysBio, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AnaptysBio, Inc.'s common stock?
AnaptysBio, Inc. (ANAB) reported common stock of $29K in Q1 2026.
How has AnaptysBio, Inc.'s common stock changed year-over-year?
AnaptysBio, Inc.'s common stock decreased by 3.3% year-over-year, from $30K to $29K.
What is the long-term trend for AnaptysBio, Inc.'s common stock?
Over 5 years (2020 to 2025), AnaptysBio, Inc.'s common stock has grown at a 0.7% compound annual growth rate (CAGR), from $27K to $28K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).